› $150,000,000 verdict in personal injury case
The evidence weighing the benefits and risks of hormone replacement therapy (HRT) in menopausal and postmenopausal women continues to tip toward the same conclusion – that taking HRT is dangerous.
Postmenopausal women who experience a slump in their sex drive may rediscover their libido by taking the male sex hormone testosterone. However, researchers are unsure if there may be a link between the use of testosterone and breast cancer, according to FoodConsumer.org.
How and when women take hormone replacement therapy (HRT) may affect their risk of heart attack, according to the Washington Post.
Medications typically taken for pain relief may help reduce the risk of some breast cancers, according to a recent article in the Journal of the National Cancer Institute.
Researchers analyzed data from 38 observational studies involving more than 2.7 million women to see whether taking non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, reduced risk of breast cancer. Inflammation may be a risk factor in cancer, the report says.
Oestrogen and progesterone are necessary hormones for reproduction which are produced naturally by a woman’s ovaries. At around the age of 50 the body slows down and eventually stops production of these hormones, which brings on the menopause or ‘change of life’. The menopause is, strictly speaking, the moment when a woman no longer has menstrual periods, but the term is generally used to describe the years leading up to and after that time.
The Reno trial involving three breast cancer survivors who are suing Wyeth is now nearing the end of its fourth week. The Nevada plaintiffs are suing Wyeth, the manufacturer of Prempro and Premarin, after they each developed breast cancer attributed to their long-term use of combination hormone replacement drugs.
